24 records found.
May 16, 2019
Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
Jun 16, 2018
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia
Jun 16, 2018
European Hematology Association: Answering the Unmet Need in One of the Most Common Types of Lymphoma: It's as Simple as A-D-C
Jun 16, 2018
European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia
Jun 15, 2018
European Hematology Association: First-in-Human CLL1-CD33 Compound CAR T Cells as a Two-Pronged Approach for the Treatment of Refractory Acute Myeloid Leukemia
Jun 15, 2018
European Hematology Association: Overall Survival Benefit of Obinutuzumab Over Rituximab When Combined With Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Comorbidities
Jun 15, 2018
European Hematology Association: AHL2011: Outstanding Disease Control With a Minimized BEACOPP Exposure and Toxicity in Patients With Advanced Hodgkin Lymphoma
Jun 15, 2018
European Hematology Association: Update on bb2121, a Promising Therapy for Patients with Heavily Pre-treated Relapsed/Refractory Multiple Myeloma
Jun 15, 2018
European Hematology Association: Iron: a double-edged Sword in Inflammation
Jun 15, 2018
European Hematology Association: Is RELEVANCE Relevant? Results of the Phase III Study of R2 vs R-chemo in First-line Follicular Lymphoma
Dec 21, 2017
First Publication of HemaSphere, the New Journal of the European Hematology Association, Now Online
Jun 24, 2017
HARMONY: European Network of Excellence in Hematology and Big Data to Present New Bench-To-Bedside Projects During the 22nd Annual Congress of the European Hematology Association
Jun 24, 2017
European Hematology Association: Multicenter Open-label Phase 2 Study of ibrutinib in Chronic Graft Versus Host Disease (cGVHD) After Failure of Corticosteroids
Jun 24, 2017
European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: An Interim Analysis of the JULIET Study
Jun 24, 2017
European Hematology Association: Bleeding or Clotting in Elderly Patients with Cancer-Associated Venous Thromboembolism: Which is Worse?
Jun 24, 2017
European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity in Patients with Advanced Stage Hodgkin Lymphoma: the GHSG HD18 Study
Jun 24, 2017
European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive non-Hodgkin Lymphoma (NHL)
Jun 23, 2017
European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing
Jun 23, 2017
European Hematology Association: Two is better than one: The Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Rapid Tumor Responses in a Phase 2 Study for Relapsed/Refractory NHL
Jun 23, 2017
European Hematology Association: Shedding New Light on the Prevention of Platelet Storage Lesion

Pages